COVID RAPID TEST KIT

Name: COVID RAPID TEST KIT
SKU: 5489
Price: 619.58 USD
Availability: InStock

Note: If the number more than 50K, then the price shall be reduced.

Category: Covid19

INSTRUCTIONS

TEST PROCEDURES

CERTIFICATES AND LICENCES

REPORTS AND APPROVALS

INSTRUCTIONS

General Instructions for use of COVID-19 antibody test kit.

SPECIMEN PREPARATION

Blood samples may be collected by finger prick or vein puncture, following routine facility procedures.
For serum samples, collect blood in a tube without anticoagulant and allow it to clot.
For plasma samples, collect blood in a tube containing anticoagulant.
Separate serum or plasma from blood as soon as possible to avoid haemolysis. Use only clear, nonhaemolysed specimens.
If collected via vein puncture, collect blood in a tube containing anticoagulant.
Whole blood samples should be tested immediately after sample collection..
Always use fresh sample.

TEST PROCEDURES

Take the fresh specimen as shown in picture below and bring the test components to room temperature if refrigerated or frozen.
When ready to test, open the pouch at the notch and remove device. Place the test device on a clean, flat surface.
Label the device with specimen’s ID number.
With the help of pipette load 25μL of serum/plasma/whole blood or add two drops of sample with the help of dropper into the sample well (S), than add 2 drops of buffer.
Interpret the result at 15-20 minutes. The results should not be interpreted after 20 minutes.

According to WHO: https://www.who.int/news-room/commentaries/detail/advice-on-the-useof-point-of-care-immunodiagnostic-tests-for-covid-19

Antibodies are produced over days to weeks after infection with the virus. The strength of antibody response depends on several factors, including age, nutritional status, severity of disease, and certain medications or infections like HIV that suppress the immune system. In some people with COVID-19, disease confirmed by molecular testing (e.g. reverse transcription polymerase chain reaction: RT-PCR), weak, late or absent antibody responses have been reported. Studies suggest that the majority of patients develop antibody response only in the second week after onset of symptoms. This means that a diagnosis of COVID-19 infection based on antibody response will often only be possible in the recovery phase, when many of the opportunities for clinical intervention or interruption of disease transmission have already passed. Antibody detection tests targeting COVID-19 may also cross-react with other pathogens, including other human coronaviruses and give falsepositive results.